Last quarter (Q0 0), Alterity Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Alterity Therapeutics's net income was $―. See Alterity Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Total Revenue	$ ―	$ ―	$ 3.93M	$ ―	$ 0.00	$ 0.00
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ 3.93M	$ ―	$ ―	$ ―
Operating Expense	$ ―	$ 23.63M	$ 18.55M	$ 20.26M	$ 14.74M	$ 13.47M
Operating Income	$ ―	$ -23.63M	$ -18.55M	$ -20.26M	$ -14.74M	$ -13.47M
Net Non Operating Interest Income Expense	$ ―	$ 268.42K	$ 16.44K	$ 2.50K	$ 20.68K	$ 17.12K
Other Income Expense	$ ―	$ -4.02M	$ -3.93M	$ -4.76M	$ -591.34K	$ -7.85K
Pretax Income	$ ―	$ -19.08M	$ -13.68M	$ -12.78M	$ -15.31M	$ -13.46M
Tax Provision	$ ―	$ 46.09K	$ 104.46K	$ 70.01K	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -19.12M	$ -13.79M	$ -12.85M	$ -15.31M	$ -13.46M
Basic EPS	$ ―	$ -0.52	$ -0.57	$ -0.53	$ -0.54	$ -0.90
Diluted EPS	$ ―	$ -0.52	$ -0.57	$ -0.53	$ -0.54	$ -0.90
Basic Average Shares	$ ―	$ 3.65B	$ 2.43B	$ 2.41B	$ 28.28M	$ 14.91M
Diluted Average Shares	$ ―	$ 3.65B	$ 2.43B	$ 24.24M	$ 28.28M	$ 14.91M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ 87.61K	$ 72.76K
Total Expenses	$ ―	$ 23.63M	$ 18.55M	$ 20.26M	$ 14.74M	$ 13.47M
Net Income From Continuing And Discontinued Operation	$ ―	$ -19.12M	$ -13.79M	$ -12.85M	$ -15.31M	$ -13.46M
Normalized Income	$ ―	$ -18.89M	$ -10.06M	$ ―	$ -15.08M	$ -13.80M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -19.08M	$ -13.68M	$ -12.78M	$ -14.74M	$ -13.47M
EBITDA	$ ―	$ -18.93M	$ -13.58M	$ -12.78M	$ -14.66M	$ -13.35M

Currency in USD

Alterity Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing